# PQ Bypass

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pq-bypass

- Industry: Medical Devices & Equipment
- Headquarters: Milpitas, US
- Website: www.pqbypass.com
- Total disclosed funding: $31M
- Latest round: Series B (Dec 20, 2018)
- Investors on record: 3

## About

Based in the US, PQ Bypass, Inc. operates as an innovative medical technology company focused on advancing vascular care through minimally invasive devices that effectively treat peripheral artery disease (PAD).PQ Bypass, Inc. specializes in developing advanced medical solutions for vascular care. Founded in Milpitas, US in 2009, the company has successfully raised funding through 6 deals. In April 2021, PQ Bypass was acquired by Endologix from Deerfield Management, Medical Technology Venture Partners, and Seroba Life Sciences. Richard Ferrari is the CEO, and the company has a current valuation of USD 64.39 mn, with a total amount raised of USD 30.90 mn, including their latest funding round, Series B, which was also for USD 30.90 mn led by Deerfield Management.PQ Bypass provides innovative healthcare solutions focused on organized vascular care, featuring flagship products that comprise advanced medical devices for the treatment of peripheral artery disease (PAD). These minimally invasive technologies aim to facilitate safe and effective treatment of vascular obstructions, enhancing patient outcomes with quicker recovery times and fewer complications compared to traditional surgical methods. The company's offerings are designed to improve care delivery efficiency, and they serve a diverse customer base of hospitals, outpatient surgical centers, and healthcare providers primarily across the United States and select international markets.PQ Bypass generates revenue through a business model centered around B2B transactions, with healthcare providers purchasing their advanced vascular solutions. The company engages in direct sales partnerships with hospitals and outpatient facilities, where pricing is determined based on negotiated contracts reflecting the volume of devices purchased. This revenue model fosters long-term relationships with healthcare providers, aligning with their goals of improving patient care and reducing healthcare costs, while also enhancing the efficiency of healthcare delivery systems.Looking ahead, PQ Bypass is focused on expanding its product offerings and market presence. Although specific details on new products were not disclosed, the recent acquisition by Endologix may influence future developments. The company aims to broaden its reach in international markets by leveraging its innovative technologies and solutions, although specific regions and timelines for expansion remain unspecified. The recent funding through the Series B round will support these growth initiatives and enhance the company's capacity to deliver effective vascular care solutions.

## Funding rounds

- Series B, Dec 20, 2018, $31M — Seroba, Deerfield Management, Medical Technology Venture Partners

## Investors

- Seroba (https://capitalatlas.ai/funds/seroba) — Series B
- Deerfield Management (https://capitalatlas.ai/funds/deerfield-management) — Series B
- Medical Technology Venture Partners (https://capitalatlas.ai/funds/medical-technology-venture-partners) — Series B